Dr. Diana Okuniewski, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 215 E Mansion St Ste 3d, Marshall, MI 49068 Phone: 269-558-0702 |
Suzanne E Vandenbrink-webb, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 215 E Mansion St, Suite 3d, Marshall, MI 49068 Phone: 269-781-1183 Fax: 888-837-4893 |
Dr. Kathryn Young, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 139 West Mansion Street, Marshall, MI 49068 Phone: 269-248-6090 Fax: 269-248-6095 |
Loriann Zettell, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13697 15 Mile Rd, Marshall, MI 49068 Phone: 269-789-4905 Fax: 269-789-7955 |
Marcia Lynn French, FNP-C Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 215 E Mansion St, Marshall, MI 49068 Phone: 289-781-3938 |
News Archive
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the European Patent Office for the patent application titled "N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL) - METHOXYCARBONYL - AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."
Pfizer Inc. announced that it has settled its litigation against Mylan Inc. and Mylan Pharmaceuticals Inc. relating to Pfizer's patents covering Detrol LA (tolterodine tartrate) extended-release capsules.
Much of what we accept as legal in medical billing would be regarded as fraud in any other sector.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis.
› Verified 2 days ago